Bank of Montreal
FENC icon

Bank of Montreal’s Fennec Pharmaceuticals FENC Stock Holding History

Bank of Montreal’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-642
Closed -$4K – 4083
2021
Q1 		$4K Sell
642
-2,753
-81% -$20.7K ﹤0.01% 4718
2020
Q4 		$25K Buy
3,395
+2,388
+237% +$18.2K ﹤0.01% 4314
2020
Q3 		$7K Sell
1,007
-748
-43% -$5.27K ﹤0.01% 4274
2020
Q2 		$14K Buy
1,755
+1,737
+9,650% +$12.9K ﹤0.01% 4008
2020
Q1 		$0 Hold
18
– – ﹤0.01% 4281
2019
Q4 		$0 Hold
18
– – ﹤0.01% 4894
2019
Q3 		$0 Sell
18
-79
-81% -$349 ﹤0.01% 4803
2019
Q2 		$0 Buy
97
+67
+223% +$284 ﹤0.01% 4925
2019
Q1 		$0 Sell
30
-154
-84% -$1.01K ﹤0.01% 4443
2018
Q4 		$1K Buy
184
+86
+88% +$601 ﹤0.01% 4522
2018
Q3 		$1K Sell
98
-1
-1% -$9 ﹤0.01% 4522
2018
Q2 		$1K Buy
99
+81
+450% +$960 ﹤0.01% 4519
2018
Q1 		$0 Hold
18
– – ﹤0.01% 4204
2017
Q4 		$0 Hold
18
– – ﹤0.01% 4214
2017
Q3 		$0 Buy
+18
New +$209 ﹤0.01% 4210

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of Montreal's FENC Position: Q2 2021 in Review

Bank of Montreal sold out of Fennec Pharmaceuticals (FENC) in Q2 2021, closing a stake of 642 shares — an estimated $4K sold.

Bank of Montreal first reported a position in FENC in Q3 2017 and held it in 15 quarters. The position peaked at $25K in Q4 2020. 39 funds tracked by Wall St. Rank hold FENC as of Q2 2021.

  • Bank of Montreal reported no remaining Fennec Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 642 Fennec Pharmaceuticals shares in Q2 2021, an estimated $4K.
  • Bank of Montreal first reported a position in Fennec Pharmaceuticals in Q3 2017 and held it in 15 quarters.
  • Bank of Montreal's Fennec Pharmaceuticals position peaked at $25K in Q4 2020.
  • 39 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.